drugset / Trial / NCT01444196
Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study is to assess the dosis of DL which is sufficient to inhibit cold urticaria symptoms.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-04
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desloratadine | Small molecule | 5 mg | Oral |
| Subject | Desloratadine | Small molecule | 20 mg | Oral |